5:19 PM · 5 February 2024

MorphoSys gains 37% amid rumours of possible takeover by Novartis

Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.

The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.

MorphoSys shares are currently gaining nearly 37%.

Source: xStation

25 August 2026, 3:37 PM

US OPEN: Falling oil prices drive risk appetite up! Nasdaq leads rebound (25.08.2026)

25 August 2026, 12:53 PM

Market Wrap: Cautious rebound in Europe after the drop in oil prices

25 August 2026, 8:07 AM

Nvidia Goes to Space. SpaceX Is Building Satellites Powered by Its Chips

25 August 2026, 6:31 AM

Morning Wrap: Strong Crypto, Weaker Nasdaq and Another Chapter in the US–Canada Trade War

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits